United States · FDA National Drug Code directory
memantine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-249_2eba035e-38ce-479d-8dc8-0bfdd2bffbcf
- Product NDC
- 68180-249
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- memantine hydrochloride
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180220
- Source listing expiry
- 20271231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 28 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-249-06) · 68180-249-06
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-249-09) · 68180-249-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →